rte0cgc8 | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Augustin%2C_M.%3B_Hallek%2C_M.%3B_Nitschmann%2C_S.>
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s00108-021-00985-3>
?:doi	10.1007/s00108-021-00985-3
?:journal	Internist_(Berl)
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/bf7d3ca93ef61df830971bb76861c7c1d1a22dc7.json
?:pmc_json_files	document_parses/pmc_json/PMC7871514.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7871514>
?:pmid	<https://research.tib.eu/covid-19/entity/33560450.0>
?:pmid	33560450.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/bf7d3ca93ef61df830971bb76861c7c1d1a22dc7>
?:source	Medline; PMC
?:title	Impfstoffentwicklung zur Prävention von COVID-19 – Teil 2
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2021-02-09

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/rte0cgc8>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/rte0cgc8>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all